These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches. Wilke C; Pujol-Calderón F; Barro C; Stransky E; Blennow K; Michalak Z; Deuschle C; Jeromin A; Zetterberg H; Schüle R; Höglund K; Kuhle J; Synofzik M Clin Chem Lab Med; 2019 Sep; 57(10):1556-1564. PubMed ID: 31251725 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis. Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P; J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123 [TBL] [Abstract][Full Text] [Related]
12. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis. Chen X; Chen Y; Wei Q; Ou R; Cao B; Zhao B; Shang HF BMC Neurol; 2016 Sep; 16():173. PubMed ID: 27634542 [TBL] [Abstract][Full Text] [Related]
13. Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. McCombe PA; Pfluger C; Singh P; Lim CY; Airey C; Henderson RD J Neurol Sci; 2015; 353(1-2):122-9. PubMed ID: 25958264 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis. Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940 [TBL] [Abstract][Full Text] [Related]
16. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259 [TBL] [Abstract][Full Text] [Related]
17. Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study. Li JY; Dai Y; Sun XH; Ren HT; Shen DC; Yang XZ; Liu MS; Cui LY Brain Behav; 2023 May; 13(5):e2997. PubMed ID: 37070132 [TBL] [Abstract][Full Text] [Related]
18. Role of plasma phosphorylated neurofilament heavy chain (pNfH) in amyotrophic lateral sclerosis. Zecca C; Dell'Abate MT; Pasculli G; Capozzo R; Barone R; Arima S; Pollice A; Brescia V; Tortelli R; Logroscino G J Cell Mol Med; 2022 Jul; 26(13):3608-3615. PubMed ID: 35715961 [TBL] [Abstract][Full Text] [Related]
19. Significance of CSF NfL and tau in ALS. Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162 [TBL] [Abstract][Full Text] [Related]
20. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis. Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]